{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:14:46Z","timestamp":1793927686851,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502783"],"award-info":[{"award-number":["82502783"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQ22H030013;2022-KY1-001-039"],"award-info":[{"award-number":["LQ22H030013;2022-KY1-001-039"]}]},{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Disease Independent Project","award":["zz202320"],"award-info":[{"award-number":["zz202320"]}]},{"name":"Young Innovative Talents Support Program of Zhejiang Medical and Health Science and Technology Project","award":["2022499572"],"award-info":[{"award-number":["2022499572"]}]},{"name":"Young Innovative Talents Support Program of Zhejiang Chinese Medicine Science Technology Project","award":["2024025437,2024ZR152"],"award-info":[{"award-number":["2024025437,2024ZR152"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2025ZFJH03"],"award-info":[{"award-number":["2025ZFJH03"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-026-00913-z","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:54:46Z","timestamp":1768874086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Restoration of ethanol-induced Bifidobacterium pseudocatenulatum depletion ameliorates alcohol-associated liver disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Yating","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"913_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-018-0021-8","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz, H. K. et al. Publisher Correction: Alcoholic liver disease. Nat. Rev. Dis. Prim. 4, 18 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"913_CR2","unstructured":"Patel, R. & Mueller, M. Alcoholic Liver Disease (StatPearls, 2022)."},{"key":"913_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","volume":"18","author":"H Wang","year":"2021","unstructured":"Wang, H., Mehal, W., Nagy, L. E. & Rotman, Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol. Immunol. 18, 73\u201391 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"913_CR4","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri, M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 68, 1516\u20131526 (2019).","journal-title":"Gut"},{"key":"913_CR5","first-page":"265","volume":"422","author":"M Kapitan","year":"2019","unstructured":"Kapitan, M., Niemiec, M. J., Steimle, A., Frick, J. S. & Jacobsen, I. D. Fungi as part of the microbiota and interactions with intestinal bacteria. Curr. Top. Microbiol. Immunol. 422, 265\u2013301 (2019).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"913_CR6","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.3390\/nu13093170","volume":"13","author":"K Pohl","year":"2021","unstructured":"Pohl, K., Moodley, P. & Dhanda, A. D. Alcohol\u2019s impact on the gut and liver. Nutrients 13, 3170 (2021).","journal-title":"Nutrients"},{"key":"913_CR7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/jvh.13344","volume":"27","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. Altered faecal microbiota on the expression of Th cells responses in the exacerbation of patients with hepatitis E infection. J. Viral Hepat. 27, 1243\u20131252 (2020).","journal-title":"J. Viral Hepat."},{"key":"913_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/00952990.2019.1669629","volume":"46","author":"K Litwinowicz","year":"2020","unstructured":"Litwinowicz, K., Choroszy, M. & Waszczuk, E. Changes in the composition of the human intestinal microbiome in alcohol use disorder: a systematic review. Am. J. Drug Alcohol Abus. 46, 4\u201312 (2020).","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"913_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.35946\/arcr.v37.2.07","volume":"37","author":"PA Engen","year":"2015","unstructured":"Engen, P. A., Green, S. J., Voigt, R. M., Forsyth, C. B. & Keshavarzian, A. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 37, 223\u2013236 (2015).","journal-title":"Alcohol Res."},{"key":"913_CR10","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/acer.13498","volume":"41","author":"JS Bajaj","year":"2017","unstructured":"Bajaj, J. S. et al. Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis. Alcohol Clin. Exp. Res. 41, 1857\u20131865 (2017).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"913_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis, M. et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65, 830\u2013839 (2016).","journal-title":"Gut"},{"key":"913_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23146-3","volume":"8","author":"D Ciocan","year":"2018","unstructured":"Ciocan, D. et al. Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis. Sci. Rep. 8, 4822 (2018).","journal-title":"Sci. Rep."},{"key":"913_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940\u2013947 (2014).","journal-title":"J. Hepatol."},{"key":"913_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/1984200","volume":"2023","author":"W Wolfe","year":"2023","unstructured":"Wolfe, W. et al. The challenge of applications of probiotics in gastrointestinal diseases. Adv. Gut Microbiome Res. 2023, 1\u201310 (2023).","journal-title":"Adv. Gut Microbiome Res."},{"key":"913_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11010-019-03651-3","volume":"464","author":"N Nie","year":"2020","unstructured":"Nie, N. et al. Bifidobacterium plays a protective role in TNF-\u03b1-induced inflammatory response in Caco-2 cell through NF-\u03baB and p38MAPK pathways. Mol. Cell. Biochem. 464, 83\u201391 (2020).","journal-title":"Mol. Cell. Biochem."},{"key":"913_CR16","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/oby.20330","volume":"21","author":"PG Cano","year":"2013","unstructured":"Cano, P. G., Santacruz, A., Trejo, F. M. & Sanz, Y. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity 21, 2310\u20132321 (2013).","journal-title":"Obesity"},{"key":"913_CR17","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1021\/acs.jafc.0c06329","volume":"69","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Bifidobacterium pseudocatenulatum ameliorates DSS-induced colitis by maintaining intestinal mechanical barrier, blocking proinflammatory cytokines, inhibiting TLR4\/NF-\u03baB signaling, and altering gut microbiota. J. Agric. Food Chem. 69, 1496\u20131512 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"913_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.02.001","volume":"132","author":"A Mizokami","year":"2017","unstructured":"Mizokami, A., Kawakubo-Yasukochi, T. & Hirata, M. Osteocalcin and its endocrine functions. Biochem. Pharm. 132, 1\u20138 (2017).","journal-title":"Biochem. Pharm."},{"key":"913_CR19","doi-asserted-by":"publisher","first-page":"116223","DOI":"10.1016\/j.celrep.2025.116223","volume":"44","author":"R Silva de Oliveira","year":"2025","unstructured":"Silva de Oliveira, R. et al. Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity. Cell Rep. 44, 116223 (2025).","journal-title":"Cell Rep."},{"key":"913_CR20","doi-asserted-by":"publisher","first-page":"115220","DOI":"10.1016\/j.celrep.2024.115220","volume":"44","author":"L Liu","year":"2025","unstructured":"Liu, L. et al. TWEAK-Fn14 signaling protects mice from pulmonary fibrosis by inhibiting fibroblast activation and recruiting pro-regenerative macrophages. Cell Rep. 44, 115220 (2025).","journal-title":"Cell Rep."},{"key":"913_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jid.2018.05.036","volume":"139","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. TWEAK\/Fn14 signals mediate burn wound repair. J. Invest. Dermatol. 139, 224\u2013234 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"913_CR22","doi-asserted-by":"publisher","first-page":"495156","DOI":"10.1155\/2013\/495156","volume":"2013","author":"H Kawaratani","year":"2013","unstructured":"Kawaratani, H. et al. The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2013, 495156 (2013).","journal-title":"Mediators Inflamm."},{"key":"913_CR23","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1046\/j.1432-1327.2001.02385.x","volume":"268","author":"T Muta","year":"2001","unstructured":"Muta, T. & Takeshige, K. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur. J. Biochem. 268, 4580\u20134589 (2001).","journal-title":"Eur. J. Biochem."},{"key":"913_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41586-025-09395-z","volume":"646","author":"C Llorente","year":"2025","unstructured":"Llorente, C. et al. mAChR4 suppresses liver disease via GAP-induced antimicrobial immunity. Nature 646, 180\u2013189 (2025).","journal-title":"Nature"},{"key":"913_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s10753-018-0923-3","volume":"42","author":"L Jin","year":"2019","unstructured":"Jin, L. et al. Degradation products of polydopamine restrained inflammatory response of LPS-stimulated macrophages through mediation TLR-4-MYD88 dependent signaling pathways by antioxidant. Inflammation 42, 658\u2013671 (2019).","journal-title":"Inflammation"},{"key":"913_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."},{"key":"913_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","volume":"70","author":"SK Sarin","year":"2019","unstructured":"Sarin, S. K., Pande, A. & Schnabl, B. Microbiome as a therapeutic target in alcohol-related liver disease. J. Hepatol. 70, 260\u2013272 (2019).","journal-title":"J. Hepatol."},{"key":"913_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-014-0240-4","volume":"14","author":"MCC Canesso","year":"2014","unstructured":"Canesso, M. C. C. et al. Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota. BMC Microbiol. 14, 240 (2014).","journal-title":"BMC Microbiol."},{"key":"913_CR29","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572\u20131585 (2011).","journal-title":"Gastroenterology"},{"key":"913_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09395-8","volume":"7","author":"D Fang","year":"2017","unstructured":"Fang, D. et al. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci. Rep. 7, 8770 (2017).","journal-title":"Sci. Rep."},{"key":"913_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1572-0241.1999.00797.x","volume":"94","author":"A Keshavarzian","year":"1999","unstructured":"Keshavarzian, A. et al. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am. J. Gastroenterol. 94, 200\u2013207 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"913_CR32","doi-asserted-by":"publisher","first-page":"G937","DOI":"10.1152\/ajpgi.00235.2001","volume":"282","author":"MA Choudhry","year":"2002","unstructured":"Choudhry, M. A., Fazal, N., Goto, M., Gamelli, R. L. & Sayeed, M. M. Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G937\u2013G947 (2002).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"913_CR33","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324\u20131332 (2007).","journal-title":"Nat. Med."},{"key":"913_CR34","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.4049\/jimmunol.148.8.2423","volume":"148","author":"Y Jiang","year":"1992","unstructured":"Jiang, Y., Beller, D. I., Frendl, G. & Graves, D. T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J. Immunol. 148, 2423\u20132428 (1992).","journal-title":"J. Immunol."},{"key":"913_CR35","first-page":"449","volume":"84","author":"N Sheron","year":"1991","unstructured":"Sheron, N., Bird, G., Goka, J., Alexander, G. & Williams, R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin. Exp. Immunol. 84, 449\u2013453 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"913_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/hep.21138","volume":"43","author":"T Gustot","year":"2006","unstructured":"Gustot, T. et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43, 989\u20131000 (2006).","journal-title":"Hepatology"},{"key":"913_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.1179721","volume":"328","author":"M Vijay-Kumar","year":"2010","unstructured":"Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228\u2013231 (2010).","journal-title":"Science"},{"key":"913_CR38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1053\/j.gastro.2014.08.033","volume":"147","author":"B Chassaing","year":"2014","unstructured":"Chassaing, B., Ley, R. E. & Gewirtz, A. T. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology 147, 1363\u20131377.e1317 (2014).","journal-title":"Gastroenterology"},{"key":"913_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.immuni.2012.09.016","volume":"38","author":"AA Koblansky","year":"2013","unstructured":"Koblansky, A. A. et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38, 119\u2013130 (2013).","journal-title":"Immunity"},{"key":"913_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jhep.2006.05.009","volume":"45","author":"C Ji","year":"2006","unstructured":"Ji, C., Chan, C. & Kaplowitz, N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J. Hepatol. 45, 717\u2013724 (2006).","journal-title":"J. Hepatol."},{"key":"913_CR41","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ajpath.2011.11.017","volume":"180","author":"W Zhong","year":"2012","unstructured":"Zhong, W. et al. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am. J. Pathol. 180, 998\u20131007 (2012).","journal-title":"Am. J. Pathol."},{"key":"913_CR42","doi-asserted-by":"publisher","first-page":"F1720","DOI":"10.1152\/ajprenal.00536.2017","volume":"315","author":"LC Li","year":"2018","unstructured":"Li, L. C. et al. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice. Am. J. Physiol. Ren. Physiol. 315, F1720\u2013F1731 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"913_CR43","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3389\/fmicb.2016.01204","volume":"7","author":"S Arboleya","year":"2016","unstructured":"Arboleya, S., Watkins, C., Stanton, C. & Ross, R. P. Gut bifidobacteria populations in human health and aging. Front. Microbiol. 7, 1204 (2016).","journal-title":"Front. Microbiol."},{"key":"913_CR44","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1039\/C9FO01813A","volume":"11","author":"Z Shi","year":"2020","unstructured":"Shi, Z. et al. Anti-obesity effects of \u03b1-amylase inhibitor enriched-extract from white common beans (Phaseolus vulgaris L.) associated with the modulation of gut microbiota composition in high-fat diet-induced obese rats. Food Funct. 11, 1624\u20131634 (2020).","journal-title":"Food Funct."},{"key":"913_CR45","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Backhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"913_CR46","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1136\/gutjnl-2019-319726","volume":"69","author":"J Rodriguez","year":"2020","unstructured":"Rodriguez, J. et al. Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut 69, 1975\u20131987 (2020).","journal-title":"Gut"},{"key":"913_CR47","doi-asserted-by":"publisher","first-page":"1707610","DOI":"10.1080\/19490976.2019.1707610","volume":"12","author":"GM Agudelo-Ochoa","year":"2020","unstructured":"Agudelo-Ochoa, G. M. et al. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes 12, 1707610 (2020).","journal-title":"Gut Microbes"},{"key":"913_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.phrs.2017.12.009","volume":"129","author":"C Mancuso","year":"2018","unstructured":"Mancuso, C. & Santangelo, R. Alzheimer\u2019s disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence. Pharmacol. Res. 129, 329\u2013336 (2018).","journal-title":"Pharmacol. Res."},{"key":"913_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.phrs.2017.12.025","volume":"130","author":"T Huc","year":"2018","unstructured":"Huc, T., Nowinski, A., Drapala, A., Konopelski, P. & Ufnal, M. Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats. Pharmacol. Res. 130, 172\u2013179 (2018).","journal-title":"Pharmacol. Res."},{"key":"913_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., De Gottardi, A. & Rescigno, M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J. Hepatol. 72, 558\u2013577 (2020).","journal-title":"J. Hepatol."},{"key":"913_CR51","doi-asserted-by":"publisher","first-page":"e0200908","DOI":"10.1371\/journal.pone.0200908","volume":"13","author":"KE Zaborska","year":"2018","unstructured":"Zaborska, K. E., Lee, S. A., Garribay, D., Cha, E. & Cummings, B. P. Deoxycholic acid supplementation impairs glucose homeostasis in mice. PLoS ONE 13, e0200908 (2018).","journal-title":"PLoS ONE"},{"key":"913_CR52","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","volume":"11","author":"S Astbury","year":"2020","unstructured":"Astbury, S. et al. Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes 11, 569\u2013580 (2020).","journal-title":"Gut Microbes"},{"key":"913_CR53","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/jn\/122.11.2066","volume":"122","author":"RF Grimble","year":"1992","unstructured":"Grimble, R. F. et al. Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet. J. Nutr. 122, 2066\u20132073 (1992).","journal-title":"J. Nutr."},{"key":"913_CR54","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1136\/gutjnl-2016-313170","volume":"67","author":"JS Bajaj","year":"2018","unstructured":"Bajaj, J. S. et al. Fungal dysbiosis in cirrhosis. Gut 67, 1146\u20131154 (2018).","journal-title":"Gut"},{"key":"913_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.alcohol.2008.12.009","volume":"43","author":"CB Forsyth","year":"2009","unstructured":"Forsyth, C. B. et al. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43, 163\u2013172 (2009).","journal-title":"Alcohol"},{"key":"913_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3350\/cmh.2017.0067","volume":"24","author":"AM Cassard","year":"2018","unstructured":"Cassard, A. M. & Ciocan, D. Microbiota, a key player in alcoholic liver disease. Clin. Mol. Hepatol. 24, 100\u2013107 (2018).","journal-title":"Clin. Mol. Hepatol."},{"key":"913_CR57","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","volume":"79","author":"Q Song","year":"2023","unstructured":"Song, Q. et al. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J. Hepatol. 79, 1352\u20131365 (2023).","journal-title":"J. Hepatol."},{"key":"913_CR58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12072-023-10518-9","volume":"18","author":"R Ganesan","year":"2024","unstructured":"Ganesan, R. et al. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease. Hepatol. Int. 18, 486\u2013499 (2024).","journal-title":"Hepatol. Int."},{"key":"913_CR59","doi-asserted-by":"publisher","first-page":"e17878","DOI":"10.1016\/j.heliyon.2023.e17878","volume":"9","author":"X Shu","year":"2023","unstructured":"Shu, X. et al. Bifidobacterium lactis TY-S01 protects against alcoholic liver injury in mice by regulating intestinal barrier function and gut microbiota. Heliyon 9, e17878 (2023).","journal-title":"Heliyon"},{"key":"913_CR60","first-page":"183","volume":"7","author":"S Iwanaga","year":"1978","unstructured":"Iwanaga, S. et al. Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis 7, 183\u2013188 (1978).","journal-title":"Haemostasis"},{"key":"913_CR61","unstructured":"Askgaard, G., Kraglund, F., Kann, A. E., Vilstrup, H. & Jepsen, P. [Epidemiology for alcohol-related liver disease]. Ugeskr. Laeger 183, V11200893 (2021)."},{"key":"913_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00253-018-9454-y","volume":"103","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats. Appl. Microbiol. Biotechnol. 103, 375\u2013393 (2019).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"913_CR63","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.3748\/wjg.v26.i40.6224","volume":"26","author":"XW Jiang","year":"2020","unstructured":"Jiang, X. W. et al. New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism. World J. Gastroenterol. 26, 6224\u20136240 (2020).","journal-title":"World J. Gastroenterol."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00913-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:04:54Z","timestamp":1770901494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00913-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["913"],"URL":"https:\/\/doi.org\/10.1038\/s41522-026-00913-z","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}